Mizuho Securities Maintains ADMA Biologics(ADMA.US) With Buy Rating, Announces Target Price $32

Moomoo NewsMar 7 03:33 ET · Ratings

Express News | ADMA Biologics Inc : Mizuho Raises Target Price to $32 From $28

ReutersMar 6 06:34 ET

How Much Upside Is Left in Adma Biologics (ADMA)? Wall Street Analysts Think 52.85%

Zacks Mar 5 09:05 ET

Mizuho Securities Maintains ADMA Biologics(ADMA.US) With Buy Rating

Moomoo NewsMar 5 00:31 ET · Ratings

Buy Rating Affirmed for ADMA Biologics Amid Transition to New Auditor and Growth Prospects

TipRanksMar 4 23:56 ET · Ratings

Cantor Fitzgerald Maintains ADMA Biologics(ADMA.US) With Buy Rating, Raises Target Price to $25

Moomoo NewsMar 4 16:31 ET · Ratings